Arkolith/Insider Trading/COGT/Form 4

Pinnow Cole

Chief Commercial OfficerCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Jan 15, 2025
Net Buying
Open-Market Buys
$333K
Open-Market Sells
$0
Net Open-Market Flow
$333K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2025Buy(P)44K$7.60$333K46K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-005630) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML